These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 759826)
1. Demonstration of a deficiency of beta-xylosidase activity in various forms of Gaucher's disease. Chiao YB; Peters SP; Diven WF; Lee RE; Glew RH Metabolism; 1979 Jan; 28(1):56-62. PubMed ID: 759826 [No Abstract] [Full Text] [Related]
2. Multiple glycosidase deficiencies in a case of juvenile (type 3) Gaucher disease. Chiao YB; Hoyson GM; Peters SP; Lee RE; Diven W; Murphy JV; Glew RH Proc Natl Acad Sci U S A; 1978 May; 75(5):2448-52. PubMed ID: 27787 [TBL] [Abstract][Full Text] [Related]
4. Multiple forms of acid phosphatase activity in Gaucher's disease. Chambers JP; Peters SP; Glew RH; Lee RE; McCafferty LR; Mercer DW; Wenger DA Metabolism; 1978 Jul; 27(7):801-14. PubMed ID: 26832 [TBL] [Abstract][Full Text] [Related]
5. Identity of beta-glucosidase, beta-xylosidase and one of the beta-galactosidase activities in human liver when assayed with 4-methylumbelliferyl-beta-D-glycosides studies in cases of Gaucher's disease. Ockerman PA Biochim Biophys Acta; 1968 Aug; 165(1):59-62. PubMed ID: 5672844 [No Abstract] [Full Text] [Related]
6. Acid hydrolases in plasma in Gaucher's disease. Ockerman PA; Kohlin P Clin Chem; 1969 Jan; 15(1):61-4. PubMed ID: 4884797 [No Abstract] [Full Text] [Related]
7. Characterization of lysosomal hydrolases that are elevated in Gaucher's disease. Moffitt KD; Chambers JP; Diven WF; Glew RH; Wenger DA; Farrell DF Arch Biochem Biophys; 1978 Sep; 190(1):247-60. PubMed ID: 101149 [No Abstract] [Full Text] [Related]
8. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver. Owada M; Sakiyama T; Kitagawa T Pediatr Res; 1977 May; 11(5):641-6. PubMed ID: 870871 [TBL] [Abstract][Full Text] [Related]
12. Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease. Garrett KO; Prence EM; Glew RH Arch Biochem Biophys; 1985 Apr; 238(1):344-52. PubMed ID: 3920967 [TBL] [Abstract][Full Text] [Related]
13. Clinical and biochemical aspects of chronic Gaucher's disease. Matoth Y; Zaizov R; Hoffman J; Klibansky C Isr J Med Sci; 1974 Dec; 10(12):1523-9. PubMed ID: 4443228 [No Abstract] [Full Text] [Related]
14. Pathology of Gaucher's disease. Kahn LB S Afr Med J; 1974 Jun; 48(26):1098-102. PubMed ID: 4843491 [No Abstract] [Full Text] [Related]
15. Gaucher's disease in the Cape coloured population of the RSA, including a family with 5 affected siblings. Swart AL; Hesseling PB; Hayden MR; Louw M; Herbert JS S Afr Med J; 1987 Jan; 71(2):97-9. PubMed ID: 3101207 [TBL] [Abstract][Full Text] [Related]
16. Acid phosphatase in spleen tissue-culture in Gaucher's disease. Perona GP; Baccichetti C; Tenconi R Lancet; 1968 Aug; 2(7563):358-9. PubMed ID: 4173779 [No Abstract] [Full Text] [Related]
17. In vitro culture of spleen cells from a case of Gaucher's disease. Fraccaro M; Magrini U; Scappaticci S; Zacchello F Ann Hum Genet; 1968 Oct; 32(2):209-13. PubMed ID: 4304418 [No Abstract] [Full Text] [Related]
18. Isolation of heat-stable glucocerebrosidase activators from the spleens of three variants of Gaucher's disease. Peters SP; Coffee CJ; Glew RH; Lee RE; Wenger DA; Li SC; Li YT Arch Biochem Biophys; 1977 Sep; 183(1):290-7. PubMed ID: 907355 [No Abstract] [Full Text] [Related]
19. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease. Basu A; Prence E; Garrett K; Glew RH; Ellingson JS Arch Biochem Biophys; 1985 Nov; 243(1):28-34. PubMed ID: 3933429 [TBL] [Abstract][Full Text] [Related]